| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 323,249 | 336,455 | 326,613 | 355,306 | | Cost of Revenue | 194,191 | 205,354 | 203,419 | 216,169 | | | Gross Profit | 129,058 | 131,101 | 123,194 | 139,137 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 79,789 | 81,116 | 81,782 | 85,310 | | Non Recurring | 2,752 | 3,250 | 2,251 | 12,719 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 46,517 | 46,735 | 39,161 | 41,108 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,382 | (385) | (191) | 1,238 | | Earnings Before Interest And Taxes | 47,899 | 46,080 | 39,240 | 42,346 | | Interest Expense | 3,951 | 4,440 | 4,821 | 5,233 | | Income Before Tax | 43,948 | 41,640 | 34,419 | 37,113 | | Income Tax Expense | 14,171 | 13,988 | 11,544 | 12,261 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,777 | 27,922 | 22,605 | 24,852 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,777 | 27,922 | 22,605 | 24,852 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,777 | $27,922 | $22,605 | $24,852 |
|
0.51% Nasdaq 
Income Statement
